Splanchnic vein thrombosis in acute pancreatitis

A single-center experience

Samar Harris, Nikhil A. Nadkarni, Harris V. Naina, Santhi Swaroop Vege

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

OBJECTIVES: This study aimed to estimate outcomes of splanchnic vein thrombosis (SVT) in hospitalized patients with acute pancreatitis (AP). METHODS: This was a retrospective study (January 1996 to December 2006) via chart review. RESULTS: Over 10 years, 1.8% (45/2454) of patients with AP with a mean (SD) age of 58 (15) years were diagnosed with SVT. Splenic vein thrombosis was the most common form of SVT (30/45 patients, 67%). Seventeen patients were anticoagulated with heparin, when the SVT was diagnosed in the acute stage followed by oral anticoagulation (AC). The thrombosis that was most commonly anticoagulated was portal vein thrombosis in 11 (65%) of 17 patients. Of 17 patients in the AC group, 2 (12%) showed recanalization as compared with 3 (11%) of 28 patients in the non-AC group (P > 0.05). The mortality was 3 (7%) of 45 (2 from the AC group versus 1 in the non-AC group, P > 0.05). Two of these died of multiorgan failure, and the other, from septic shock. None of the deaths were due to bleeding complications. CONCLUSIONS: Splanchnic vein thrombosis occurred in 1.8% patients of AP. The use of AC was reasonably safe with no fatal bleeding complications. However, there was no significant difference in the recanalization rates in those with and without AC.

Original languageEnglish (US)
Pages (from-to)1251-1254
Number of pages4
JournalPancreas
Volume42
Issue number8
DOIs
StatePublished - Nov 2013

Fingerprint

Viscera
Pancreatitis
Veins
Thrombosis
Oral Stage
Splenic Vein
Hemorrhage
Septic Shock
Portal Vein
Heparin
Retrospective Studies
Mortality

Keywords

  • acute pancreatitis
  • splanchnic veins
  • venous thrombosis

ASJC Scopus subject areas

  • Hepatology
  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Splanchnic vein thrombosis in acute pancreatitis : A single-center experience. / Harris, Samar; Nadkarni, Nikhil A.; Naina, Harris V.; Vege, Santhi Swaroop.

In: Pancreas, Vol. 42, No. 8, 11.2013, p. 1251-1254.

Research output: Contribution to journalArticle

Harris, Samar ; Nadkarni, Nikhil A. ; Naina, Harris V. ; Vege, Santhi Swaroop. / Splanchnic vein thrombosis in acute pancreatitis : A single-center experience. In: Pancreas. 2013 ; Vol. 42, No. 8. pp. 1251-1254.
@article{4d04926d49714f22a9c6ab230e5be8be,
title = "Splanchnic vein thrombosis in acute pancreatitis: A single-center experience",
abstract = "OBJECTIVES: This study aimed to estimate outcomes of splanchnic vein thrombosis (SVT) in hospitalized patients with acute pancreatitis (AP). METHODS: This was a retrospective study (January 1996 to December 2006) via chart review. RESULTS: Over 10 years, 1.8{\%} (45/2454) of patients with AP with a mean (SD) age of 58 (15) years were diagnosed with SVT. Splenic vein thrombosis was the most common form of SVT (30/45 patients, 67{\%}). Seventeen patients were anticoagulated with heparin, when the SVT was diagnosed in the acute stage followed by oral anticoagulation (AC). The thrombosis that was most commonly anticoagulated was portal vein thrombosis in 11 (65{\%}) of 17 patients. Of 17 patients in the AC group, 2 (12{\%}) showed recanalization as compared with 3 (11{\%}) of 28 patients in the non-AC group (P > 0.05). The mortality was 3 (7{\%}) of 45 (2 from the AC group versus 1 in the non-AC group, P > 0.05). Two of these died of multiorgan failure, and the other, from septic shock. None of the deaths were due to bleeding complications. CONCLUSIONS: Splanchnic vein thrombosis occurred in 1.8{\%} patients of AP. The use of AC was reasonably safe with no fatal bleeding complications. However, there was no significant difference in the recanalization rates in those with and without AC.",
keywords = "acute pancreatitis, splanchnic veins, venous thrombosis",
author = "Samar Harris and Nadkarni, {Nikhil A.} and Naina, {Harris V.} and Vege, {Santhi Swaroop}",
year = "2013",
month = "11",
doi = "10.1097/MPA.0b013e3182968ff5",
language = "English (US)",
volume = "42",
pages = "1251--1254",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Splanchnic vein thrombosis in acute pancreatitis

T2 - A single-center experience

AU - Harris, Samar

AU - Nadkarni, Nikhil A.

AU - Naina, Harris V.

AU - Vege, Santhi Swaroop

PY - 2013/11

Y1 - 2013/11

N2 - OBJECTIVES: This study aimed to estimate outcomes of splanchnic vein thrombosis (SVT) in hospitalized patients with acute pancreatitis (AP). METHODS: This was a retrospective study (January 1996 to December 2006) via chart review. RESULTS: Over 10 years, 1.8% (45/2454) of patients with AP with a mean (SD) age of 58 (15) years were diagnosed with SVT. Splenic vein thrombosis was the most common form of SVT (30/45 patients, 67%). Seventeen patients were anticoagulated with heparin, when the SVT was diagnosed in the acute stage followed by oral anticoagulation (AC). The thrombosis that was most commonly anticoagulated was portal vein thrombosis in 11 (65%) of 17 patients. Of 17 patients in the AC group, 2 (12%) showed recanalization as compared with 3 (11%) of 28 patients in the non-AC group (P > 0.05). The mortality was 3 (7%) of 45 (2 from the AC group versus 1 in the non-AC group, P > 0.05). Two of these died of multiorgan failure, and the other, from septic shock. None of the deaths were due to bleeding complications. CONCLUSIONS: Splanchnic vein thrombosis occurred in 1.8% patients of AP. The use of AC was reasonably safe with no fatal bleeding complications. However, there was no significant difference in the recanalization rates in those with and without AC.

AB - OBJECTIVES: This study aimed to estimate outcomes of splanchnic vein thrombosis (SVT) in hospitalized patients with acute pancreatitis (AP). METHODS: This was a retrospective study (January 1996 to December 2006) via chart review. RESULTS: Over 10 years, 1.8% (45/2454) of patients with AP with a mean (SD) age of 58 (15) years were diagnosed with SVT. Splenic vein thrombosis was the most common form of SVT (30/45 patients, 67%). Seventeen patients were anticoagulated with heparin, when the SVT was diagnosed in the acute stage followed by oral anticoagulation (AC). The thrombosis that was most commonly anticoagulated was portal vein thrombosis in 11 (65%) of 17 patients. Of 17 patients in the AC group, 2 (12%) showed recanalization as compared with 3 (11%) of 28 patients in the non-AC group (P > 0.05). The mortality was 3 (7%) of 45 (2 from the AC group versus 1 in the non-AC group, P > 0.05). Two of these died of multiorgan failure, and the other, from septic shock. None of the deaths were due to bleeding complications. CONCLUSIONS: Splanchnic vein thrombosis occurred in 1.8% patients of AP. The use of AC was reasonably safe with no fatal bleeding complications. However, there was no significant difference in the recanalization rates in those with and without AC.

KW - acute pancreatitis

KW - splanchnic veins

KW - venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84887292184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887292184&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e3182968ff5

DO - 10.1097/MPA.0b013e3182968ff5

M3 - Article

VL - 42

SP - 1251

EP - 1254

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 8

ER -